首页> 外国专利> IDENTIFICATION OF CANCER GENES BY IN-VIVO FUSION OF HUMAN CANCER CELLS AND ANIMAL CELLS

IDENTIFICATION OF CANCER GENES BY IN-VIVO FUSION OF HUMAN CANCER CELLS AND ANIMAL CELLS

机译:通过体内融合人类癌细胞和动物细胞鉴定癌症基因

摘要

The present invention concerns compositions and methods for detecting and identifying novel cancer genes. The technique involves in vivo fusion of human cancer cells and animal cells, preferably hamster stromal cells, to form hybrid human cancer-animal cells, followed by identification of genes that are overexpressed in the hybrid cells compared to normal or transformed animal cells. The novel oncogenes or their protein products may be utilized for detection and/or diagnosis of human cancer or for development of new cancer therapies targeted against the novel oncogenes or their expressed proteins.
机译:本发明涉及用于检测和鉴定新型癌症基因的组合物和方法。该技术涉及人癌细胞与动物细胞(优选仓鼠基质细胞)的体内融合,以形成杂种人癌症-动物细胞,然后鉴定与正常或转化的动物细胞相比在杂种细胞中过表达的基因。新型致癌基因或其蛋白产物可用于检测和/或诊断人类癌症或用于开发针对新型致癌基因或其表达的蛋白质的新型癌症疗法。

著录项

  • 公开/公告号EP3186365A4

    专利类型

  • 公开/公告日2018-04-25

    原文格式PDF

  • 申请/专利权人 IMMUNOMEDICS INC.;

    申请/专利号EP20150836548

  • 发明设计人 GOLDENBERG DAVID M.;CHANG CHIEN-HSING;

    申请日2015-08-26

  • 分类号C12N5/28;C12Q1/6886;

  • 国家 EP

  • 入库时间 2022-08-21 13:18:49

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号